Clinical Trial Update: Evaluation of Carebot AI MMG Medical Device for Breast Lesion Detection and Density Assessment

View source ↗

Summary

Clinical trial evaluating the Carebot AI MMG medical device for breast lesion detection and density assessment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Breast Tumor
• Breast Cancer

Snippet

Sponsor: Carebot s.r.o. | Conditions: Breast Cancer, Breast Tumor Benign | Status: COMPLETED